Kopran Limited has informed the Exchange about Amalgamation/Merger
KOPRAN · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Kopran Limited has received a 'no objection' observation letter from NSE on February 27, 2026, for its proposed scheme of merger by absorption of Kopran Laboratories Limited (Transferor) into Kopran Limited (Transferee). SEBI had already shared its observations on the draft scheme on February 26, 2026. The scheme, originally approved by Kopran's board on March 20, 2025, is being pursued under Sections 230-232 of the Companies Act, 2013. The NSE observation letter is valid for six months, within which the company must file the scheme with NCLT. SEBI has also flagged that the share notice must prominently disclose any increase in promoter shareholding post-merger, along with rationale, swap ratio, financials of both entities, and details of any pending actions against promoters or directors.
This is an internal group-level restructuring (not a third-party acquisition) that clears a key regulatory milestone, moving the scheme closer to NCLT and shareholder approval. Public shareholders should watch for the shareholder meeting notice, as SEBI's observations suggest promoter shareholding could rise after the merger. The stock may see some event-driven activity, but the deal is not yet effective — shareholder, creditor, and NCLT approvals are still pending.